Lenalidomide plus dexamethasone versus observation in patients with high-risk smouldering multiple myeloma (QuiRedex): long-term follow-up of a randomised, controlled, phase 3 trial.
about
Diagnosis and management of smoldering multiple myeloma: the razor's edge between clonality and cancer.Elotuzumab for the Treatment of Relapsed or Refractory Multiple Myeloma, with Special Reference to its Modes of Action and SLAMF7 Signaling.Volumetry based biomarker speed of growth: Quantifying the change of total tumor volume in whole-body magnetic resonance imaging over time improves risk stratification of smoldering multiple myeloma patients.Baseline mutational patterns and sustained MRD negativity in patients with high-risk smoldering myelomaMultiple myelomaCheckpoint Inhibition in Myeloma: Opportunities and ChallengesMultiple myeloma: 2018 update on diagnosis, risk‐stratification, and managementGenomic patterns of progression in smoldering multiple myelomaTiming of treatment of smoldering myeloma: early treatment
P2860
Q34557651-60CBE3CF-3BB6-4B2C-8542-94A72C0DDD9AQ55310350-2037E4A6-5A6E-46E5-A76B-C7947B28F7D6Q55356619-DEC9926C-0C91-4AE3-91DB-68D49B5A8DCBQ56528114-AF1BDAF4-2A2A-4DCC-A50D-D8D2A98F7866Q56657250-72EC7442-A17A-4EE0-8BEC-22F5D9F397E1Q57491415-367169C4-DC27-4E37-B119-BCD23AD66146Q58565204-A7EB842A-4D58-4250-8B2C-C5C7162C8D94Q58721686-22446743-1B15-40BD-A9C1-06C599FA9208Q59137899-DDC2B55E-98F0-4E64-A196-DD0B3B10A916
P2860
Lenalidomide plus dexamethasone versus observation in patients with high-risk smouldering multiple myeloma (QuiRedex): long-term follow-up of a randomised, controlled, phase 3 trial.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Lenalidomide plus dexamethason ...... ed, controlled, phase 3 trial.
@en
type
label
Lenalidomide plus dexamethason ...... ed, controlled, phase 3 trial.
@en
prefLabel
Lenalidomide plus dexamethason ...... ed, controlled, phase 3 trial.
@en
P2093
P50
P1433
P1476
Lenalidomide plus dexamethason ...... sed, controlled, phase 3 trial
@en
P2093
Bruno Paiva
Felipe de Arriba
Javier López
Jesús-F San Miguel
Joan Bargay
Joan Bladé
José-María Arguiñano
Juan-José Lahuerta
Laura Rosiñol
Lucía López Corral
P304
P356
10.1016/S1470-2045(16)30124-3
P577
2016-07-09T00:00:00Z